Nifty
Sensex
:
:
11247.55
38067.93
25.15 (0.22%)
94.71 (0.25%)

Pharmaceuticals & Drugs - Domestic

Rating :
76/99

BSE: 531599 | NSE: FDC

356.15
30-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  363.00
  •  368.00
  •  355.00
  •  365.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  256767
  •  924.04
  •  379.00
  •  158.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,242.23
  • 22.67
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,215.70
  • 0.22%
  • 3.81

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.24%
  • 1.84%
  • 15.16%
  • FII
  • DII
  • Others
  • 5.31%
  • 5.07%
  • 3.38%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.57
  • 6.22
  • 7.73

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.85
  • 5.07
  • 5.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.79
  • 7.33
  • 11.45

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.40
  • 20.73
  • 19.56

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.93
  • 3.06
  • 2.79

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.73
  • 13.10
  • 12.59

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
308.18
343.52
-10.29%
333.33
270.67
23.15%
321.22
256.17
25.39%
346.12
273.82
26.40%
Expenses
204.60
265.04
-22.80%
304.04
227.62
33.57%
236.40
199.68
18.39%
272.25
216.45
25.78%
EBITDA
103.58
78.48
31.98%
29.29
43.05
-31.96%
84.82
56.49
50.15%
73.87
57.36
28.78%
EBIDTM
33.61%
22.84%
14.01%
15.90%
26.41%
22.05%
21.34%
20.95%
Other Income
27.97
9.79
185.70%
37.76
13.92
171.26%
31.03
13.98
121.96%
16.90
8.69
94.48%
Interest
0.75
0.81
-7.41%
0.99
0.36
175.00%
0.79
0.35
125.71%
0.82
0.32
156.25%
Depreciation
9.44
9.36
0.85%
9.32
7.90
17.97%
9.20
7.51
22.50%
9.57
9.03
5.98%
PBT
121.36
78.09
55.41%
56.73
47.61
19.16%
105.77
62.62
68.91%
80.38
56.70
41.76%
Tax
29.44
21.73
35.48%
0.86
11.21
-92.33%
31.51
16.54
90.51%
25.97
16.45
57.87%
PAT
91.92
56.36
63.09%
55.88
36.39
53.56%
74.25
46.08
61.13%
54.41
40.25
35.18%
PATM
29.83%
16.41%
7.11%
13.44%
23.12%
17.99%
15.72%
14.70%
EPS
5.38
3.30
63.03%
3.27
2.13
53.52%
4.34
2.69
61.34%
3.18
2.35
35.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,308.85
1,344.19
1,090.70
1,075.07
1,013.87
994.32
889.31
845.85
772.83
710.54
711.67
Net Sales Growth
14.39%
23.24%
1.45%
6.04%
1.97%
11.81%
5.14%
9.45%
8.77%
-0.16%
 
Cost Of Goods Sold
4,936.70
425.72
345.14
352.08
339.05
357.93
272.91
266.16
311.11
237.54
253.93
Gross Profit
-3,627.85
918.46
745.56
722.99
674.81
636.38
616.40
579.69
461.71
473.00
457.75
GP Margin
-277.18%
68.33%
68.36%
67.25%
66.56%
64.00%
69.31%
68.53%
59.74%
66.57%
64.32%
Total Expenditure
1,017.29
1,051.25
859.68
848.38
770.40
765.58
690.76
641.47
591.97
547.15
545.76
Power & Fuel Cost
-
27.40
24.61
22.00
21.55
23.14
20.18
18.45
16.85
13.77
12.73
% Of Sales
-
2.04%
2.26%
2.05%
2.13%
2.33%
2.27%
2.18%
2.18%
1.94%
1.79%
Employee Cost
-
277.48
225.57
216.67
191.08
175.76
137.58
122.05
107.52
99.02
85.57
% Of Sales
-
20.64%
20.68%
20.15%
18.85%
17.68%
15.47%
14.43%
13.91%
13.94%
12.02%
Manufacturing Exp.
-
61.14
62.25
58.77
49.40
36.44
97.27
88.65
22.88
70.20
67.06
% Of Sales
-
4.55%
5.71%
5.47%
4.87%
3.66%
10.94%
10.48%
2.96%
9.88%
9.42%
General & Admin Exp.
-
58.06
59.45
61.55
53.35
49.97
41.43
35.99
34.32
33.79
31.76
% Of Sales
-
4.32%
5.45%
5.73%
5.26%
5.03%
4.66%
4.25%
4.44%
4.76%
4.46%
Selling & Distn. Exp.
-
94.70
78.92
75.96
64.36
57.73
64.96
58.43
56.15
55.45
55.12
% Of Sales
-
7.05%
7.24%
7.07%
6.35%
5.81%
7.30%
6.91%
7.27%
7.80%
7.75%
Miscellaneous Exp.
-
106.74
63.73
61.35
51.61
64.61
56.43
51.73
43.13
37.36
55.12
% Of Sales
-
7.94%
5.84%
5.71%
5.09%
6.50%
6.35%
6.12%
5.58%
5.26%
5.56%
EBITDA
291.56
292.94
231.02
226.69
243.47
228.74
198.55
204.38
180.86
163.39
165.91
EBITDA Margin
22.28%
21.79%
21.18%
21.09%
24.01%
23.00%
22.33%
24.16%
23.40%
23.00%
23.31%
Other Income
113.66
68.90
43.47
50.96
50.22
39.00
45.72
42.00
46.36
28.65
28.25
Interest
3.35
3.42
1.44
1.40
1.41
1.40
1.81
3.10
1.60
1.41
1.44
Depreciation
37.53
37.46
33.24
35.14
34.62
33.73
38.81
24.91
27.90
18.43
17.36
PBT
364.24
320.97
239.80
241.11
257.65
232.62
203.65
218.36
197.72
172.20
175.37
Tax
87.78
80.08
66.85
67.12
63.30
63.48
55.51
83.04
42.55
38.11
24.48
Tax Rate
24.10%
24.95%
28.01%
27.84%
25.14%
27.29%
27.26%
38.03%
21.52%
22.13%
13.96%
PAT
276.46
240.89
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
PAT before Minority Interest
276.46
240.89
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
21.12%
17.92%
15.76%
16.18%
18.59%
17.01%
16.66%
16.00%
20.08%
18.87%
21.20%
PAT Growth
54.38%
40.17%
-1.23%
-7.68%
11.43%
14.17%
9.48%
-12.79%
15.72%
-11.13%
 
EPS
16.17
14.09
10.05
10.17
11.02
9.89
8.66
7.91
9.07
7.84
8.82

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,547.43
1,445.24
1,276.11
1,270.20
1,082.47
936.38
845.30
784.24
695.42
616.39
Share Capital
17.10
17.52
17.52
17.86
17.86
17.86
17.86
18.16
18.37
18.54
Total Reserves
1,530.33
1,427.72
1,258.59
1,252.34
1,064.61
918.52
827.43
766.08
677.05
597.86
Non-Current Liabilities
314.62
229.17
211.41
216.67
19.93
24.06
30.97
31.32
30.24
29.59
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.22
0.56
0.77
Unsecured Loans
0.34
0.49
0.60
0.69
0.79
0.90
1.07
1.24
1.45
1.73
Long Term Provisions
295.78
213.96
194.12
198.60
0.50
0.56
0.00
0.00
0.00
2.20
Current Liabilities
564.62
497.43
480.07
389.40
163.42
187.97
195.69
153.97
139.01
123.45
Trade Payables
117.86
77.61
97.32
75.10
82.59
87.17
80.05
61.04
57.64
45.90
Other Current Liabilities
80.06
61.67
68.78
64.11
50.16
36.61
42.87
35.98
30.09
29.60
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
1.00
1.11
1.14
1.29
1.27
Short Term Provisions
366.69
358.15
313.97
250.19
30.67
63.19
71.66
55.81
49.99
46.68
Total Liabilities
2,426.67
2,171.84
1,967.59
1,876.27
1,265.82
1,148.41
1,071.96
969.53
864.67
769.43
Net Block
673.50
682.19
673.64
678.05
675.16
393.04
284.40
289.19
293.04
276.74
Gross Block
844.97
817.80
776.49
745.84
708.81
629.67
470.42
453.02
430.01
396.15
Accumulated Depreciation
171.47
135.61
102.84
67.79
33.65
236.62
186.02
163.82
136.96
119.41
Non Current Assets
1,181.25
1,113.46
976.64
957.93
742.46
646.27
619.47
558.20
418.02
322.50
Capital Work in Progress
23.85
12.38
12.84
6.32
19.92
28.80
18.10
7.22
10.72
10.18
Non Current Investment
162.31
179.11
74.07
54.49
39.43
216.72
186.92
245.15
96.20
14.01
Long Term Loans & Adv.
320.83
239.08
215.28
218.46
7.70
6.37
128.71
15.13
17.41
19.42
Other Non Current Assets
0.75
0.71
0.81
0.60
0.25
1.33
1.33
1.51
0.65
2.15
Current Assets
1,245.41
1,058.38
990.94
918.34
523.36
502.13
452.03
410.83
446.10
446.88
Current Investments
502.24
405.93
397.16
436.53
285.41
272.49
229.90
170.91
243.92
248.86
Inventories
209.96
173.79
160.49
137.16
130.91
123.22
103.00
99.71
102.92
97.42
Sundry Debtors
123.74
87.53
81.66
76.06
61.94
61.04
59.36
43.23
41.97
40.75
Cash & Bank
32.32
21.26
29.30
28.47
18.02
14.95
23.43
36.50
16.78
17.76
Other Current Assets
377.15
11.32
10.68
9.68
27.10
30.44
36.33
60.49
40.52
42.09
Short Term Loans & Adv.
350.34
358.56
311.65
230.44
20.36
14.77
28.18
48.89
34.66
39.71
Net Current Assets
680.79
560.94
510.87
528.94
359.94
314.16
256.33
256.86
307.09
323.43
Total Assets
2,426.66
2,171.84
1,967.58
1,876.27
1,265.82
1,148.40
1,071.97
969.53
864.66
769.44

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
250.38
112.43
149.84
154.49
174.30
127.64
149.72
149.94
144.33
120.74
PBT
319.95
237.75
240.63
257.71
232.15
203.65
218.36
197.72
172.20
175.37
Adjustment
22.58
-2.95
0.39
-10.88
2.41
-1.40
-7.67
-14.20
-2.62
1.31
Changes in Working Capital
-7.77
-48.30
-23.24
-19.23
-4.54
-11.78
7.09
4.14
9.01
-20.98
Cash after chg. in Working capital
334.77
186.49
217.78
227.60
230.02
190.48
217.79
187.66
178.59
155.70
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-84.39
-74.06
-67.94
-70.14
-55.73
-62.84
-68.07
-37.72
-34.26
-34.97
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-2.97
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-98.35
-120.33
20.11
-143.55
-73.05
-88.57
-55.38
-107.18
-108.25
-33.00
Net Fixed Assets
-38.52
-40.93
-36.71
-24.24
-81.62
-169.89
-28.28
-19.51
-25.53
-17.54
Net Investments
-79.51
-113.70
19.79
-166.18
170.44
-72.39
-0.76
-75.95
-83.31
-33.71
Others
19.68
34.30
37.03
46.87
-161.87
153.71
-26.34
-11.72
0.59
18.25
Cash from Financing Activity
-142.00
-0.07
-169.43
0.35
-96.98
-47.76
-75.25
-62.83
-58.18
-57.51
Net Cash Inflow / Outflow
10.03
-7.96
0.52
11.29
4.27
-8.69
19.09
-20.06
-22.10
30.22
Opening Cash & Equivalents
19.92
28.13
27.10
16.25
12.17
23.26
4.17
24.23
46.33
16.11
Closing Cash & Equivalent
29.88
19.92
28.13
27.10
16.25
14.56
23.26
4.17
24.23
46.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
90.51
82.86
73.17
71.42
60.87
52.62
47.47
43.30
37.95
33.35
ROA
10.48%
8.30%
9.05%
12.00%
14.01%
13.34%
13.26%
16.92%
16.41%
20.83%
ROE
16.10%
12.63%
13.67%
16.02%
16.76%
16.64%
16.63%
21.01%
20.48%
26.44%
ROCE
21.63%
17.64%
19.04%
21.51%
23.15%
23.02%
27.12%
26.85%
26.34%
30.73%
Fixed Asset Turnover
1.66
1.37
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
Receivable days
27.96
28.31
26.58
23.96
22.06
24.19
21.70
19.72
20.88
19.59
Inventory Days
50.80
55.93
50.15
46.55
45.58
45.45
42.89
46.90
50.57
47.41
Payable days
38.50
40.35
41.32
40.83
44.81
47.89
44.12
40.39
37.33
32.94
Cash Conversion Cycle
40.26
43.89
35.41
29.68
22.84
21.74
20.47
26.23
34.12
34.06
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Interest Cover
94.95
166.95
172.62
179.60
167.11
113.30
71.41
124.23
122.88
122.86

News Update:


  • FDC launches two variants of Favipiravir drug for Covid-19
    26th Aug 2020, 09:10 AM

    The company’s PiFLU and Favenza is currently available across the country.

    Read More
  • FDC inks pact to acquire additional stake in FDC SA
    8th Aug 2020, 08:53 AM

    The company would be holding 93% of the equity share capital of FOCSA, whereby FOC SA would become a subsidiary of the company

    Read More
  • FDC - Quarterly Results
    7th Aug 2020, 19:08 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.